| Literature DB >> 30217676 |
Yuichi Takashi1, Seiji Fukumoto2.
Abstract
Fibroblast growth factor (FGF) 23 is a bone-derived phosphotropic hormone that regulates phosphate and vitamin D metabolism. FGF23 mainly affects kidney function via the FGF receptor (FGFR)/α-Klotho complex. The physiological roles of FGF23 and α-Klotho in the regulation of mineral homeostasis have been well established. In addition, recent studies have reported that FGF23 has various effects on many other tissues, sometimes in an α-Klotho-independent manner, especially under pathological conditions. However, how FGF23 works in these tissues without α-Klotho is not entirely clear. Here we review the recent reports concerning the actions of FGF23 on various tissues and discuss the remaining questions about FGF23.Entities:
Keywords: chronic kidney disease; fibroblast growth factor 23; fibroblast growth factor receptor; phosphate; α-Klotho
Mesh:
Substances:
Year: 2018 PMID: 30217676 DOI: 10.1016/j.tem.2018.08.006
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015